Ley General de Transparencia y acceso a la Información Pública Ley Nº 27806
subtitul
“We hope that ACRO’s D&I Site Resource Grants Program will help to elevate these seven projects as proof-of-concept initiatives to show the broader industry that a small investment can go a long way toward improving representation in clinical trials,” said Tafoya Hubbard, Grants Program Manager, ACRO.
ACRO’s Diversity & Inclusion in Clinical Trials Committee accepted applications from a broad range of sites, from community-based sites that needed upskilling or support to attract industry studies to more established sites aiming to increase the representativeness of participants enrolled in their studies. ACRO will work with grant recipients over the next 12 months to track their progress and provide support. The Site Resource Grants Program will then culminate in a white paper illustrating the lessons learned over the course of the Program.
“The clinical research and clinical technology companies of ACRO are key connectors of sponsors, sites, and trial participants,” said Doug Peddicord, Executive Director, ACRO. “We are extremely excited to inaugurate this project, which aims to try out varying approaches to improving the diversity of clinical trial populations and look forward to reporting out on the results and insights.”
Brooklyn Clinical Research – New York